Does anyone have any insight on the current Healthcare PE teams at UMM/MFs? (ie. vertical focuses, culture, returns)
Would be interesting to know considering recent deals in the industry (Medline) and the current bidding war on Novartis' Sandoz.
| +106 | Is Everyone Too Bearish on PE? | 34 | 18h |
| +48 | Why would anyone do PE in long term in 2026? | 13 | 1d |
| +24 | Q&A: What It’s Actually Like Working at an Independent (Fundless) Sponsor | 4 | 3d |
| +22 | Do you think PE has actually helped you become a better entrepreneur? | 8 | 10h |
| +21 | MF Tech PE 2026 | 4 | 1h |
| +21 | UMM PE or High Paying Strat Finance? | 13 | 1d |
| +21 | Striking out in last rounds | 2 | 4d |
| +16 | Portfolio Marks | 8 | 7h |
| +15 | DELETE | 1 | 2d |
| +15 | Overwhelmed by amount of data / granularity | 3 | 2d |
Career Resources
Get instant access to lessons taught by experienced private equity pros and bulge bracket investment bankers including financial statement modeling, DCF, M&A, LBO, Comps and Excel Modeling.
Intern in IB-M&A, bummer your thread hasn't had a response yet. Sometimes bots are smarter than humans anyways:
More suggestions...
Hope that helps.
Assumenda ea et qui aspernatur voluptatem aut et. Et qui autem doloremque illo dolorum. Aperiam qui ex sunt voluptatem officiis. Atque doloribus et laudantium dignissimos.
Reiciendis tempore quia perspiciatis quia assumenda sit id magnam. Animi itaque assumenda quis omnis quisquam ipsa hic.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...